Dermatofibrosarcoma Protuberans

被引:0
|
作者
Alvaro E. Acosta
Catalina Santa Vélez
机构
[1] Instituto Nacional de Cancerología,Dermatology Department
[2] Universidad Nacional de Colombia,Dermatology Oncology Universidad Militar Nueva Granada
[3] Instituto Nacional de Cancerología,undefined
来源
关键词
Dermatofibrosarcoma protuberans; Mohs micrographic surgery; Imatinib mesylate; Radiotherapy; Pathology; Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
Dermatofibrosarcoma protuberans (DFSP) is a slow growing tumor with a very low metastatic potential but with significant subclinical extension and great capacity for local destruction. Thus, the first surgeon approached with such challenging tumor must attempt to cure the patient with a method that spares healthy tissue and ensures an optimal oncological, functional, and esthetic result. The treatment of DFSP often requires a multidisciplinary approach. Depending on location, dermatologic surgeons, surgical oncologists, head and neck surgeons, neurosurgeons, plastic surgeons, and occasionally medical oncologists may be involved with the management. Mohs micrographic surgery (MMS) is the preferred method when available. In our institution, most of the DFSP cases are often advanced cases; thus, dermatologic surgeons obtain clear margins peripherally and other surgical specialties assist with resection of the fascia and any critical deeper structures. When MMS is not available, wide local excision (at least 2- to 3-cm margins of resection) with exhaustive pathologic assessment of margin status is recommended, and it is best to confirm tumor extirpation prior to any reconstruction. Subclinical extension of the tumor could be related to the size; how long it has been growing or histological markers that are unknown right now. No clinical trials comparing MMS vs WLE are available, and further research should be focused on these subjects as well as the use of imatinib and other targeted therapies for recurrent and metastatic tumors and for neoadjuvant treatment.
引用
下载
收藏
相关论文
共 50 条
  • [31] DERMATOFIBROSARCOMA PROTUBERANS
    MOPPER, C
    ARCHIVES OF DERMATOLOGY, 1957, 76 (02) : 258 - 258
  • [32] DERMATOFIBROSARCOMA PROTUBERANS
    WADDINGTON, E
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1954, 46 (11): : 906 - 907
  • [33] DERMATOFIBROSARCOMA PROTUBERANS
    GUTIERREZ, G
    OSPINA, JE
    DEBAEZ, NE
    DEESCORCIA, EK
    GUTIERREZ, R
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1984, 23 (06) : 396 - 401
  • [34] Dermatofibrosarcoma protuberans
    Garcia, C
    Clark, RE
    Buchanan, M
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (12) : 867 - 871
  • [35] Dermatofibrosarcoma protuberans
    Dimitropoulos, Vassilios A.
    DERMATOLOGIC THERAPY, 2008, 21 (06) : 428 - 432
  • [36] DERMATOFIBROSARCOMA PROTUBERANS
    WEBER, PJ
    GRETZULA, JC
    HEVIA, O
    GARLAND, LB
    BARQUIN, P
    GOULD, E
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1988, 14 (05): : 555 - 558
  • [37] Dermatofibrosarcoma Protuberans
    Miller, Stanley J.
    Alam, Murad
    Andersen, James S.
    Berg, Daniel
    Bichakjian, Christopher K.
    Bowen, Glen M.
    Cheney, Richard T.
    Frank Glass, L.
    Grekin, Roy C.
    Ho, Alan L.
    Kessinger, Anne
    Liegeois, Nanette
    Lydiatt, Daniel D.
    Michalski, Jeff
    Morrison, William H.
    Nehal, Kishwer S.
    Nelson, Kelly C.
    Nghiem, Paul
    Olencki, Thomas
    Perlis, Clifford S.
    Shaha, Ashok R.
    Tuli, Malika
    Urist, Marshall M.
    Wang, Linda C.
    Zic, John A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (03): : 312 - 318
  • [38] DERMATOFIBROSARCOMA PROTUBERANS
    LASKIN, WB
    CA-A CANCER JOURNAL FOR CLINICIANS, 1992, 42 (02) : 116 - 125
  • [39] DERMATOFIBROSARCOMA PROTUBERANS
    SIMSTEIN, NL
    TUTHILL, RJ
    SPERBER, EE
    KOVALCIK, PJ
    MULLEN, JT
    SOUTHERN MEDICAL JOURNAL, 1977, 70 (04) : 487 - 489
  • [40] Dermatofibrosarcoma Protuberans
    Li, Jing
    Ge, Xin
    Ma, Jian-Min
    Li, Ming
    OPHTHALMOLOGY, 2012, 119 (01) : 197 - 197